Ritholtz Wealth Management’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$413K Sell
6,559
-102
-2% -$7.13K 0.01% 922
2026
Q1
$503K Buy
6,661
+286
+4% +$20.4K 0.01% 786
2025
Q4
$393K Sell
6,375
-94
-1% -$5.53K 0.01% 800
2025
Q3
$380K Sell
6,469
-93
-1% -$5.42K 0.01% 761
2025
Q2
$382K Buy
+6,562
New +$371K 0.01% 717
2024
Q3
– Sell
-15,587
Closed -$794K – 896
2024
Q2
$794K Sell
15,587
-1,658
-10% -$90.8K 0.03% 412
2024
Q1
$937K Buy
17,245
+243
+1% +$12.7K 0.03% 376
2023
Q4
$958K Buy
17,002
+47
+0.3% +$2.66K 0.04% 340
2023
Q3
$1.05M Buy
16,955
+5,667
+50% +$359K 0.05% 266
2023
Q2
$667K Sell
11,288
-2,399
-18% -$153K 0.03% 366
2023
Q1
$1.01M Buy
13,687
+7,617
+125% +$588K 0.05% 259
2022
Q4
$443K Sell
6,070
-10,575
-64% -$835K 0.02% 385
2022
Q3
$1.39M Buy
16,645
+13,364
+407% +$1.15M 0.07% 187
2022
Q2
$261K Buy
+3,281
New +$319K 0.02% 441

Other funds holding NTR

Ritholtz Wealth Management's NTR Position: Q2 2026 in Review

Ritholtz Wealth Management reduced its Nutrien (NTR) stake by 1.5% in Q2 2026, selling an estimated $7.13K and leaving 6,559 shares worth $413K. The position accounts for 0.01% of the portfolio, ranked #922.

Ritholtz Wealth Management first reported a position in NTR in Q2 2022 and has held it in 14 quarters since. The position peaked at $1.39M in Q3 2022. 734 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • Ritholtz Wealth Management held 6,559 shares of Nutrien worth $413K as of Q2 2026.
  • Ritholtz Wealth Management sold 102 Nutrien shares in Q2 2026, an estimated $7.13K.
  • Nutrien made up 0.01% of Ritholtz Wealth Management's portfolio in Q2 2026, its #922 holding.
  • Ritholtz Wealth Management first reported a position in Nutrien in Q2 2022 and has held it in 14 quarters since.
  • Ritholtz Wealth Management's Nutrien position peaked at $1.39M in Q3 2022.
  • 734 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on Ritholtz Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.